FindTrial
Sign In

Comparasion Study of ropivacaine and bupivacaine in Sonographic guided TAP block in Laproscopic Chollecystectomy

A comparative study of isobaric bupivacaine 0.25 percentage and ropivacine 0.375 percentage in ultrasound – guided transversus abdominis plane block for postoperative analgesia in laparoscopic cholecystectomy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070800
Enrollment
80
Registered
2024-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K801- Calculus of gallbladder with othercholecystitis Health Condition 2: K829- Disease of gallbladder, unspecified

Interventions

Intervention1: TRANSVERUS ABDOMINIS PLANE BLOCK: After preparing the abdomen, ultrasound transducer was positioned horizontally across the abdomen. The muscle layers in the antero-lateral part of the

Sponsors

Mahatma Gandhi Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status I/II Patients scheduled for Laparoscopic cholecystectomy surgery

Exclusion criteria

Exclusion criteria: Patient with known psychiatric disorders, coagulopathy disorders, Pregnant and Lactating patients Inability to understand VAS scoring, Infection at local needle site insertion

Design outcomes

Primary

MeasureTime frame
A comparassion of isobaric bupivacaine 0.25% and ropivacine 0.375% in ultrasound – guided, transversus abdominis plane block for postoperative analgesia in laparoscopic cholecystectomy Timepoint: To study Pain score using of visual analogue score(VAS) during the first 24 hours—

Secondary

MeasureTime frame
Time to first rescue analgesia To study complications, if any Timepoint: at diffrent time intervals—

Countries

India

Contacts

Public ContactDr Ayush Satishkumar Gupta

Mahatma Gandhi Medical College and Hospital, Jaipur

doctorprachi.verma@gmail.com9784041694

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026